Fig. 3From: Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group RegistryExploratory analyses of the impact of sunitinib on overall survival. a OS 2nd line, all other drugs group may or may not have had sunitinib later. b OS 2nd line, all other drugs group excludes patients that had sunitinib at a later timeBack to article page